These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 23949795)

  • 1. IL-2/anti-IL-2 complex: a novel strategy of in vivo regulatory T cell expansion in renal injury.
    Wang YM; Alexander SI
    J Am Soc Nephrol; 2013 Oct; 24(10):1503-4. PubMed ID: 23949795
    [No Abstract]   [Full Text] [Related]  

  • 2. IL-2/anti-IL-2 complex attenuates renal ischemia-reperfusion injury through expansion of regulatory T cells.
    Kim MG; Koo TY; Yan JJ; Lee E; Han KH; Jeong JC; Ro H; Kim BS; Jo SK; Oh KH; Surh CD; Ahn C; Yang J
    J Am Soc Nephrol; 2013 Oct; 24(10):1529-36. PubMed ID: 23833258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The IL-2/Anti-IL-2 Complex Attenuates Cardiac Ischaemia-Reperfusion Injury Through Expansion of Regulatory T Cells.
    Xiao J; Yu K; Li M; Xiong C; Wei Y; Zeng Q
    Cell Physiol Biochem; 2017; 44(5):1810-1827. PubMed ID: 29224017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine therapy with interleukin-2/anti-interleukin-2 monoclonal antibody complexes expands CD4+CD25+Foxp3+ regulatory T cells and attenuates development and progression of atherosclerosis.
    Dinh TN; Kyaw TS; Kanellakis P; To K; Tipping P; Toh BH; Bobik A; Agrotis A
    Circulation; 2012 Sep; 126(10):1256-66. PubMed ID: 22851544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superagonistic CD28 Protects against Renal Ischemic Injury by Expansion of Regulatory T-Cell.
    Liang Y; Li Y; Kuang Q; Ding X; Wei Z; Fang Y
    Am J Nephrol; 2017; 45(5):389-399. PubMed ID: 28355607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disruption of TIM-4 in dendritic cell ameliorates hepatic warm IR injury through the induction of regulatory T cells.
    Li J; Zhao X; Liu X; Liu H
    Mol Immunol; 2015 Aug; 66(2):117-25. PubMed ID: 25771178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-2/anti-interleukin-2 monoclonal antibody immune complex suppresses collagen-induced arthritis in mice by fortifying interleukin-2/STAT5 signalling pathways.
    Lee SY; Cho ML; Oh HJ; Ryu JG; Park MJ; Jhun JY; Park MK; Stone JC; Ju JH; Hwang SY; Park SH; Surh CD; Kim HY
    Immunology; 2012 Dec; 137(4):305-16. PubMed ID: 23167249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-IL-2 anti-IL-4 monoclonal antibodies do not synergize in the suppression of mouse renal cancer.
    Takeuchi T
    J Chemother; 2010 Jun; 22(3):215-6. PubMed ID: 20566430
    [No Abstract]   [Full Text] [Related]  

  • 9. Combination Therapy Using IL-2/IL-2 Monoclonal Antibody Complexes, Rapamycin, and Islet Autoantigen Peptides Increases Regulatory T Cell Frequency and Protects against Spontaneous and Induced Type 1 Diabetes in Nonobese Diabetic Mice.
    Manirarora JN; Wei CH
    J Immunol; 2015 Dec; 195(11):5203-14. PubMed ID: 26482409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-2/IL-2Ab complexes induce regulatory T cell expansion and protect against proteinuric CKD.
    Polhill T; Zhang GY; Hu M; Sawyer A; Zhou JJ; Saito M; Webster KE; Wang Y; Wang Y; Grey ST; Sprent J; Harris DC; Alexander SI; Wang YM
    J Am Soc Nephrol; 2012 Aug; 23(8):1303-8. PubMed ID: 22677553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective stimulation of T cell subsets with antibody-cytokine immune complexes.
    Boyman O; Kovar M; Rubinstein MP; Surh CD; Sprent J
    Science; 2006 Mar; 311(5769):1924-7. PubMed ID: 16484453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-2/anti-IL-2 complexes ameliorate lupus nephritis by expansion of CD4
    Yan JJ; Lee JG; Jang JY; Koo TY; Ahn C; Yang J
    Kidney Int; 2017 Mar; 91(3):603-615. PubMed ID: 27914701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo expansion of activated naive CD8+ T cells and NK cells driven by complexes of IL-2 and anti-IL-2 monoclonal antibody as novel approach of cancer immunotherapy.
    Tomala J; Chmelova H; Mrkvan T; Rihova B; Kovar M
    J Immunol; 2009 Oct; 183(8):4904-12. PubMed ID: 19801515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of murine allergic airway disease by IL-2:anti-IL-2 monoclonal antibody-induced regulatory T cells.
    Wilson MS; Pesce JT; Ramalingam TR; Thompson RW; Cheever A; Wynn TA
    J Immunol; 2008 Nov; 181(10):6942-54. PubMed ID: 18981114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-2-Anti-IL-2 Monoclonal Antibody Immune Complexes Inhibit Collagen-Induced Arthritis by Augmenting Regulatory T Cell Functions.
    Yokoyama Y; Iwasaki T; Kitano S; Satake A; Nomura S; Furukawa T; Matsui K; Sano H
    J Immunol; 2018 Oct; 201(7):1899-1906. PubMed ID: 30143591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentiating Tissue-Resident Type 2 Innate Lymphoid Cells by IL-33 to Prevent Renal Ischemia-Reperfusion Injury.
    Cao Q; Wang Y; Niu Z; Wang C; Wang R; Zhang Z; Chen T; Wang XM; Li Q; Lee VWS; Huang Q; Tan J; Guo M; Wang YM; Zheng G; Yu D; Alexander SI; Wang H; Harris DCH
    J Am Soc Nephrol; 2018 Mar; 29(3):961-976. PubMed ID: 29295873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effect of CD4(+)CD25(high)CD127(low) regulatory T cells in renal ischemia-reperfusion injury.
    Jun C; Ke W; Qingshu L; Ping L; Jun D; Jie L; Bo C; Su M
    Cell Immunol; 2014; 289(1-2):106-11. PubMed ID: 24754976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective sparing of T suppressor cells by anti interleukin-2 receptor monoclonal antibodies (IL-2R mAbs) in vitro correlates with their therapeutic effects in vivo.
    Tanaka K; Turka LA; Ueda H; Diamantstein T; Milford EL; Carpenter CB; Tilney NL; Kupiec-Weglinski JW
    Transplant Proc; 1989 Feb; 21(1 Pt 1):475-6. PubMed ID: 2523145
    [No Abstract]   [Full Text] [Related]  

  • 19. Interleukin-2/Anti-Interleukin-2 Immune Complex Attenuates Cardiac Remodeling after Myocardial Infarction through Expansion of Regulatory T Cells.
    Zeng Z; Yu K; Chen L; Li W; Xiao H; Huang Z
    J Immunol Res; 2016; 2016():8493767. PubMed ID: 27144181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-IL-6 receptor antibody suppressed T cell activation by inhibiting IL-2 production and inducing regulatory T cells.
    Yoshida H; Hashizume M; Suzuki M; Mihara M
    Eur J Pharmacol; 2010 May; 634(1-3):178-83. PubMed ID: 20184875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.